Screening and verification of hub genes in esophageal squamous cell carcinoma by integrated analysis

• Published in: Scientific reports Vol. 14; no. 1; p. 6894
• Main Authors: Wu, Hongqiang, Zhu, Peiyao, Shu, Peng, Zhang, Shuguang
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 22.03.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/114; 631/67; Bioinformatics; Bioinformatics analysis; CDC6; Cell cycle; Cell division; DNA biosynthesis; ESCC; Esophageal cancer; Esophageal carcinoma; Gene expression; Genes; Genomes; GEO; Humanities and Social Sciences; Immunohistochemistry; multidisciplinary; Science; Science (multidisciplinary); Squamous cell carcinoma; Therapeutic targets; Tumorigenesis; Western blotting; GEO; Bioinformatics analysis; CDC6; ESCC
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-57320-7

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors. However, the mechanisms underlying ESCC tumorigenesis have not been fully elucidated. Thus, we aimed to determine the key genes involved in ESCC tumorigenesis. The following bioinformatics analyses were performed: identification of differentially expressed genes (DEGs); gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis; integrated analysis of the protein–protein interaction network and Gene Expression Profiling Interactive Analysis database for validation of hub genes. Finally, western blotting and qPCR were used to explore the expression of cell division cycle 6 (CDC6) in ESCC cell lines. Immunohistochemistry analysis of ESCC samples from patients and matched clinical characteristics was used to determine the effects of CDC6. A total of 494 DEGs were identified, and functional enrichment was mainly focused on cell cycle and DNA replication. Biological pathway analysis of the hub genes was closely related to the cell cycle. We found that CDC6 was upregulated in ESCC cell lines and patient tissues and was related to the clinicopathological characteristics of ESCC. In conclusion, this study identified hub genes and crucial biological pathways related to ESCC tumorigenesis and integrated analyses indicated that CDC6 may be a novel diagnostic and therapeutic target for ESCC.